| Using circulating tumor DNA in colorectal cancer: current and evolving practices M Malla, JM Loree, PM Kasi, AR Parikh Journal of Clinical Oncology 40 (24), 2846-2857, 2022 | 167 | 2022 |
| Colon cancer, version 3.2024, NCCN clinical practice guidelines in oncology AB Benson, AP Venook, M Adam, G Chang, YJ Chen, KK Ciombor, ... Journal of the National Comprehensive Cancer Network 22 (2D), 2024 | 66 | 2024 |
| Sarcomatoid carcinoma of the urinary bladder M Malla, JF Wang, R Trepeta, A Feng, J Wang Clinical Genitourinary Cancer 14 (5), 366-372, 2016 | 60 | 2016 |
| NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines AB Benson, AP Venook, M Adam, G Chang, YJ Chen, KK Ciombor, ... Journal of the National Comprehensive Cancer Network 22 (6), 366-375, 2024 | 24 | 2024 |
| Microtubule inhibitors and cardiotoxicity AM Joshi, GS Prousi, C Bianco, M Malla, A Guha, M Shah, SA Brown, ... Current oncology reports 23, 1-8, 2021 | 23 | 2021 |
| To treat or not to treat: a rare case of pseudo‐thrombotic thrombocytopenic purpura in a Jehovah's Witness M Malla, M Seetharam Transfusion 56 (1), 160-163, 2016 | 20 | 2016 |
| Kinetics of postoperative circulating cell-free DNA and impact on minimal residual disease detection rates in patients with resected stage I-III colorectal cancer. SA Cohen, PM Kasi, VN Aushev, DL Hanna, GP Botta, S Sharif, ... Journal of clinical oncology 41 (4_suppl), 5-5, 2023 | 19 | 2023 |
| Immunotherapy in gastroesophageal cancers: Current evidence and ongoing trials J Huynh, K Patel, J Gong, M Cho, M Malla, A Parikh, S Klempner Current treatment options in oncology 22, 1-18, 2021 | 19 | 2021 |
| Azacitidine‐induced pericarditis: a case series M Newman, M Malla, I Gojo Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (4 …, 2016 | 17 | 2016 |
| The evolving role of radiation in pancreatic cancer M Malla, F Fekrmandi, N Malik, H Hatoum, S George, RM Goldberg, ... Frontiers in Oncology 12, 1060885, 2023 | 16 | 2023 |
| Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma. GP Botta, M Abdelrahim, VN Aushev, A Esmail, B Drummond, S Sharma, ... Journal of Clinical Oncology 40 (4_suppl), 517-517, 2022 | 13 | 2022 |
| Tumor-informed assessment of circulating tumor DNA and its incorporation into practice for patients with hepatobiliary cancers PM Kasi, G Budde, F Dayyani, GP Botta, A Diehl, GT King, M Malla, ... J Clin Oncol 39 (15_suppl), 4103-4103, 2021 | 11 | 2021 |
| Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib JC Avalon, J Fuqua, T Miller, S Deskins, C Wakefield, A King, ... Cardio-Oncology 7, 1-8, 2021 | 10 | 2021 |
| Recent advances in the management of anal cancer L Upadhyay, M Hartzell, AR Parikh, MR Strickland, S Klempner, M Malla Healthcare 11 (23), 3010, 2023 | 7 | 2023 |
| Life-threatening immune checkpoint inhibitor-induced myocarditis and myasthenia gravis overlap syndrome treated with abatacept: A case report C Wakefield, C Shultz, B Patel, M Malla BMJ Case Reports CP 14 (11), e244334, 2021 | 7 | 2021 |
| Updates in the treatment of metastatic colorectal cancer M Malla, KS Pedersen, AR Parikh JNCCN Journal of the National Comprehensive Cancer Network 21 (55), 567-571, 2023 | 5 | 2023 |
| Index admission and thirty-day readmission outcomes of patients with cancer presenting with STEMI M Osman, MM Benjamin, S Balla, B Kheiri, C Bianco, PP Sengupta, ... Cardiovascular Revascularization Medicine 35, 121-128, 2022 | 5 | 2022 |
| Comprehensive characterization of mesothelin expression in colorectal cancer. M Malla, SK Deshmukh, S Wu, J Xiu, AP Farrell, HJ Lenz, E Lou, S Goel, ... Journal of Clinical Oncology 41 (4_suppl), 245-245, 2023 | 3 | 2023 |
| 319MO Real-world monitoring of circulating tumor DNA reliably predicts cancer recurrence in patients with resected stages I-III colorectal cancer SA Cohen, PM Kasi, VN Aushev, DL Hanna, GP Botta, S Sharif, G Laliotis, ... Annals of Oncology 33, S683-S684, 2022 | 3 | 2022 |
| Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer M Malla, SK Deshmukh, S Wu, T Samec, DC Olevian, R El Naili, ... Cancer gene therapy 31 (10), 1547-1558, 2024 | 2 | 2024 |
